Worried by the spread of deadly COVID-19, pharma companies have asked the government to set up a mechanism under which imports of raw materials (active pharmaceutical ingredients) from China, are tested in laboratories, once imports are resumed.from Business News: Latest News on Business, Stock Markets, Financial News, India Business & World Business News https://ift.tt/39Bav4Y
